Prostate-specific membrane antigen (PSMA) is highly expressed in PCa, which gradually
increases in high-grade tumors, metastatic tumors, and tumors nonresponsive to androgen …

Prostate specific membrane antigen positron emission tomography (PSMA PET) is an
excellent molecular imaging technique for prostate cancer. Currently, PSMA PET for patients …

Purpose We aimed to compare the diagnostic performance and biodistribution of two similar
PET agents,[68Ga] Ga-P16-093 and [68Ga] Ga-PSMA-11, in the same group of primary …

Radioisotope-labeled prostate-specific membrane antigen (PSMA) PET tracers have gained
popularity in diagnosing prostate cancer (PCa). This study aimed to improve the affinity and …

Head-to-Head Comparison of 68Ga-P16-093 and 68Ga-PSMA-617 PE... : Clinical Nuclear
Medicine Head-to-Head Comparison of 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT in …

Purpose Prostate cancer (PCa), characterized by tumor heterogeneity, may exhibit low or
absent prostate-specific membrane antigen (PSMA) expression in cancerous lesions …

Accurate assessment and characterization of the progression and therapy response of
prostate cancer are essential for precision healthcare of patients diagnosed with the …

Objective 68 Ga-NGUL is a novel prostate-specific membrane antigen (PSMA)-targeting
tracer based on Glu-Urea-Lys derivatives conjugated to a 1, 4, 7-triazacyclononane-N, N …

Theranostics is a new term which involves the integration of therapy and diagnosis in a
single platform. Prostate-specific membrane antigen (PSMA) has emerged to be a novel …

Purpose The use of gallium-68 prostate-specific membrane antigen-11 positron emission
tomography/computed tomography (Ga-68 PSMA-11 PET/CT) is becoming increasingly …